Co-morbidities, management and clinical outcome of auto-immune Addison's disease

Endocrine

Volumn 38, Issue 1, 2010, Pages 113-117

  Leelarathna, Lalantha ^a   Breen, Louise ^a   Powrie, James K ^a   Thomas, Stephen M ^a   Guzder, Rustom ^a   McGowan, Barbara ^a   Carroll, Paul V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Addison's disease; Adrenal insufficiency; Bone density

Indexed keywords

CORTISONE ACETATE; CYANOCOBALAMIN; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; PRASTERONE; PREDNISOLONE;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BONE DENSITY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; CYANOCOBALAMIN DEFICIENCY; DOSE RESPONSE; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; LUMBAR SPINE; MALE; OBESITY; OSTEOPENIA; OSTEOPOROSIS; PATIENT EDUCATION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 77955341031     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9359-8     Document Type: Article

References (17)

1. W Arlt B Allolio 2003 Adrenal insufficiency Lancet 361 9372 1881 1893 10.1016/S0140-6736(03)13492-7 1:CAS:528:DC%2BD3sXkt1artr0%3D 12788587 (Pubitemid 36645187)
2. K Lovas ES Husebye 2002 High prevalence and increasing incidence of Addison's disease in western Norway Clin. Endocrinol. (Oxf) 56 6 787 791 10.1046/j.1365-2265.2002.t01-1-01552.x (Pubitemid 34785911)
3. L Leelarathna JK Powrie PV Carroll 2009 Thomas Addison's disease after 154 years: modern diagnostic perspectives on an old condition Q. J. Med. (QJM) 102 8 569 573 1:STN:280:DC%2BD1MrgtVKnug%3D%3D
4. K Lovas JH Loge ES Husebye 2002 Subjective health status in Norwegian patients with Addison's disease Clin. Endocrinol. (Oxf) 56 5 581 588 10.1046/j.1365-2265.2002.01466.x (Pubitemid 34595724)
5. S Hahner M Loeffler M Fassnacht, et al. 2007 Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis 2007 J. Clin. Endocrinol. Metab. 92 10 3912 3922 10.1210/jc.2007-0685 1:CAS:528:DC%2BD2sXht1SmtbbI 17684047 (Pubitemid 47607641)
6. MM Erichsen K Løvås B Skinningsrud, et al. 2009 Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry J. Clin. Endocrinol. Metab. 94 12 4882 4890 10.1210/jc.2009-1368 1:CAS:528:DC%2BD1MXhsFyltb7M 19858318
7. R Bergthorsdottir M Leonsson-Zachrisson A Oden, et al. 2006 Premature mortality in patients with Addison's disease: a population-based study J. Clin. Endocrinol. Metab. 91 12 4849 4853 10.1210/jc.2006-0076 1:CAS:528: DC%2BD28XhtlGru7zN 16968806 (Pubitemid 44917317)
8. S Bensing L Brandt F Tabaroj, et al. 2008 Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency Clin. Endocrinol. (Oxf) 69 5 697 704 10.1111/j.1365-2265.2008.03340.x
9. JA Kanis LJ Melton C Christiansen, et al. 1994 The diagnosis of osteoporosis Bone Miner. Res. 9 8 1137 1141 10.1002/jbmr.5650090802 1:STN:280:DyaK2M%2FmslSisA%3D%3D
10. CM Florkowski SJ Holmes JR Elliot, et al. 1994 Bone mineral density is reduced in female but not male subjects with Addison's disease N. Z. Med. J. 107 972 52 53 1:STN:280:DyaK2c7lvFamtA%3D%3D 8115069
11. PM Zelissen RJ Croughs PP van Rijk, et al. 1994 Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease Ann. Intern. Med. 120 3 207 210 1:STN:280:DyaK2c%2FpvFGksQ%3D%3D 8273983
12. E Jodar MP Valdepenas G Martinez 2003 Long-term follow-up of bone mineral density in Addison's disease Clin. Endocrinol. (Oxf) 58 5 617 620 10.1046/j.1365-2265.2003.01761.x (Pubitemid 36566804)
13. GD Braatvedt M Joyce M Evans 1999 Bone mineral density in patients with treated Addison's disease Osteoporos. Int. 10 6 435 440 10.1007/s001980050251 1:STN:280:DC%2BD3c7ltlaqsg%3D%3D 10663342 (Pubitemid 30029008)
14. EM Gurnell PJ Hunt SE Curran, et al. 2008 Long-term DHEA replacement in primary adrenal insufficiency. a randomized, controlled trial J. Clin. Endocrinol. Metab. 93 2 400 409 10.1210/jc.2007-1134 1:CAS:528: DC%2BD1cXit1Snt7k%3D 18000094 (Pubitemid 351240809)
15. G Johannsson R Bergthorsdottir AG Nilsson, et al. 2009 Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study Eur. J. Endocrinol. 161 1 119 130 10.1530/EJE-09-0170 1:CAS:528:DC%2BD1MXovVKktbs%3D 19383806
16. M Debono C Ghobadi A Rostami-Hodjegan, et al. 2009 Modified-release hydrocortisone to provide circadian cortisol profiles Clin. Endocrinol. Metab. 94 5 1548 1554 10.1210/jc.2008-2380 1:CAS:528:DC%2BD1MXlvVCqtro%3D
17. S Marzotti A Falorni 2004 Addisons's disease Autoimmunity 37 333 336 10.1080/08916930410001705466 1:CAS:528:DC%2BD2cXnslansLs%3D 15518054 (Pubitemid 39172924)